Combivent® Respimat®(ipratropium bromide and albuterol) Inhalation Spray Launch—Basic Instruction and Usage

Presented by Doug Gardenhire, EdD, RRT-NPS

Combivent® Respimat® Packaging

Boehringer Ingelheim Pharmaceuticals, Inc. (BI) is introducing its COMBIVENT RESPIMAT inhaler to the United States market. They have teamed up with the American Association for Respiratory Care (AARC) to provide live webcasts about the inhaler. The webcasts will:

  • explain how the inhaler works
  • demonstrate the technique for patient use
  • discuss the changes in dosage
  • provide a question and answer period at the end

Registration

Select one of the times below to register. You will receive an e-mail confirmation and instructions about how to join the webcast. Registrants for the live webcasts will be sent a placebo version of the inhaler so that they can see the COMBIVENT RESPIMAT inhaler in actual operation.

NOTE: Three broadcasts are available throughout the day but attendance is limited. Sign up early to assure you can attend the session that is most convenient for you. These webcasts are not approved for continuing education.

October 9, 2012

Registration is now closed. An archived version of this webcast will be available soon.

 

October 25, 2012

Registration is now closed. An email has been sent to all registrants. If you need an email resent, please contact Customer Service at 972-243-2272 or info@aarc.org

The event is hosted by AARC and supported by Boehringer Ingelheim.

If you are unable to attend a live event, a recorded version will be available after October 25.

Are you a member of the AARC?

Yes, I am a member

No, I am not a member

Non-members will be asked for contact information so that we can send you a Combivent Respimat placebo